The US Food and Drug Administration recently approved the first pill with an embedded digital ingestion tracking system for patients with schizophrenia, bipolar disorder, and depression.
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved Simponi Aria for 2 new indications in adult patients.
Antithrombotic medications are some of the most commonly prescribed medications. In a recent study, researchers investigated whether use of these drugs was associated with increased risk of...
The ideal timing of renal replacement therapy in critically ill patients with acute kidney injury remains unclear, despite extensive previous studies. In a recent meta-analysis, researchers sought to...
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved a new option for adult patients with tardive dyskinesia.
A recent meta-analysis sought to address this gap by examining studies that assessed the safety and efficacy of SSRIs and SNRIs in children with various psychiatric disorders.
After a review of existing data, the Endocrine Society has released several recommendations and statements regarding the treatment of symptoms associated with estrogen depletion following breast cancer. ...
A recent study investigated pharmacokinetic interactions between phosphodiesterase type 5 inhibitors and endothelin receptor antagonists used in combination for the treatment of pulmonary arterial...
A new drug candidate being developed to treat patients with chronic obstructive pulmonary disease would improve the delivery of medication to the lungs.
